Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology Spain
    Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific Antibodies
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology All
    Enhancing HCP Education in Maternal Vaccination
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Saudi Arabia
    Diagnosis and Treatment of Cancer Cachexia
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic Diseases
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    2026 Hemophilia Fellowship – United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease All
    Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi Arabia
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Saudi Arabia
    Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing Equity
    Release Date:
    Review Process: Expert Review Panel
    Education Inflammation & Immunology Australia
    Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in Türkiye
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Turkey
    Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in Türkiye
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Turkey
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    An Accord for a Healthier World: Digital Health Tools to Improve Multidisciplinary Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Support for the Professions Senegal
    PARP-inhibitor Combination Treatments in Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology China
    Improving cancer care in patients with metastatic breast cancer
    Release Date:
    Review Process: Pfizer Internal
    Translation:(link)
    Translation:(link)
    Quality Improvement Oncology Kazakhstan
    An Accord for a Healthier World: Preceptorships for Rheumatology (African French Speaking Countries Geographic Scope)
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Inflammation & Immunology All
    Improving Health Equity in IBD through Disparities Research
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Emerging Science in the Management of Acute Myeloid Leukemia
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Addressing Systemic Drivers of Racial Health Inequities
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Health Equity USA
    Diversity in Postmarketing Drug Safety Surveillance
    Release Date:
    Review Process: Pfizer Internal
    Research Patient Safety USA
    Addressing Barriers to Care: Destigmatizing Breast Cancer through Patient Education
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Ghana, Rwanda
    Increasing Awareness and Understanding of Duchenne Muscular Dystrophy in Latin America, Africa, Middle East and Asia-Pacific
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Improving Education Disparities of Young Gatroenterologists to Deliver Appropriate Medical Care to IBD Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Argentina, Brazil, India, Malaysia, Mexico, Russia, Saudi Arabia, Singapore, Turkey, United Arab Emirates
    2023 Inflammatory Bowel Disease (IBD) Fellowship – India
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology India